Effects of Telmisartan Combined with Nifedipine Controlled Release Tablet on Inflammatory Fac-Tors,vascular Endothelial Function and Left Ventricular Function in Patients with Coronary Heart Disease with Mild to Moderate Hypertension
GUO Feng,ZHANG Bao-wei,ZHU Zheng-yan
DOI: https://doi.org/10.13210/j.cnki.jhmu.20171010.001
2017-01-01
Abstract:Objective:To investigate the effect of telmisartan combined with Nifedipine Controlled Release Tablet on in-flammatory factors,vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension.Methods:A total of 92 cases of patients with coronary heart disease with mild to moderate hyperten-sion were selected as the object of observation,according to the random data table,they were divided into the control group(n=46)and observation group(n=46),and patients in the control group were treated with Nifedipine Controlled Release Table therapy,on this basis,the observation group patients were given telmisartan treatment,two groups were treated for 6 months. The levels of the blood pressure,inflammatory factors,vascular endothelial function and left ventricular function were com-pared between the two groups before and after treatment.Results:There were no significant differences in the levels of SBP, DBP,hs-CRP,TNF-α,NO,ET-1,LVEF,LVEDD and LVESD in the two groups before treatment(P>0.05);After treat-ment,two groups of SBP,DBP,hs-CRP,TNF-α,ET-1,LVEDD and LVESD levels were significantly lower than those in the same group before treatment(P<0.05),and after treatment,the levels of SBP,DBP,hs-CRP,TNF-α,ET-1 and LVESD in the observation group were significantly lower than those in the control group(P< 0.05),while there were no significant difference in the level of LVEDD between the two groups after treatment(P>0.05);Compared with level in the group before treatment,the levels of NO and LVEF in the two groups were significantly increased(P<0.05),and the observation group [(82.13 ± 19.01)μmol/L,(52.83 ± 7.45)%]was significantly higher than the control group[(67.37 ± 13.08)μmol/L,(49.47 ± 6.96)%](P<0.05).Conclusion:Telmisartan combined with Nifedipine Controlled Release Table in treating coronary heart disease with mild to moderate hypertension,can effectively control blood pressure,reduce the inflammatory stress,improve vascular endothelial function and left ventricular function of patients,has an important clinical value.